# A Study to Learn About the Study Medicine Abrocitinib in People With Severe Atopic Dermatitis Who Have Switched From Other Therapies

> **NCT07887867** · — · NOT_YET_RECRUITING · sponsor: **Pfizer** · enrollment: 120 (estimated)

## Conditions studied

- Dermatitis, Atopic

## Interventions

- **DRUG:** abrocitinib

## Key facts

- **NCT ID:** NCT07887867
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-10-01
- **Primary completion:** 2027-10-01
- **Final completion:** 2028-08-31
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2026-10-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07887867

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07887867, "A Study to Learn About the Study Medicine Abrocitinib in People With Severe Atopic Dermatitis Who Have Switched From Other Therapies". Retrieved via MORVS 2026-11-22 from https://api.morvs.ai/clinical/NCT07887867. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
